Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-08

Clinical Trial Update: Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 trial update for VIR-3434 in healthy volunteers and patients with chronic hepatitis B; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIR-3434

Snippet

Sponsor: Vir Biotechnology, Inc. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED | Results posted: 2024-10-08